HomeIRLAB-A • STO
add
IRLAB Therapeutics AB
Previous close
kr 12.20
Day range
kr 11.70 - kr 12.35
Year range
kr 5.58 - kr 20.20
Market cap
616.28M SEK
Avg Volume
30.20K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 42.78M | 522.66% |
Operating expense | 10.18M | -21.71% |
Net income | -7.06M | 84.28% |
Net profit margin | -16.50 | 97.48% |
Earnings per share | — | — |
EBITDA | -3.95M | 90.98% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 98.27M | -37.17% |
Total assets | 214.61M | -6.69% |
Total liabilities | 144.92M | 232.26% |
Total equity | 69.69M | — |
Shares outstanding | 51.87M | — |
Price to book | 9.10 | — |
Return on assets | -7.26% | — |
Return on capital | -11.13% | — |
Cash Flow
Net change in cash
(SEK) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -7.06M | 84.28% |
Cash from operations | 107.00K | 100.20% |
Cash from investing | — | — |
Cash from financing | 25.03M | 2,899.33% |
Net change in cash | 25.13M | 146.81% |
Free cash flow | -171.25K | 99.52% |
About
Founded
2013
Website
Employees
32